Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Case report

Mycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiency

Authors: Blandine Rammaert, Louis-Jean Couderc, Elisabeth Rivaud, Patrick Honderlick, David Zucman, Marie-France Mamzer, Pierre Cahen, Emmanuel Bille, Marc Lecuit, Olivier Lortholary, Emilie Catherinot

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

Mycobacterium genavense is a rare nontuberculous mycobacteria (NTM). Human infections are mostly disseminated in the setting of the AIDS epidemic or the use of aggressive immunosuppressive treatments. M. genavense culture is fastidious, requiring supplemented media. Pulmonary involvement rarely occurs as a primary localization.

Cases presentation

We report here two patients with pneumonia as the predominant manifestation of M. genavense infection: one kidney transplanted patient and one HIV-infected patient. Both patients were initially treated with anti-tuberculous drugs before the identification of M. genavense on sputum or broncho-alveolar lavage fluid culture. A four-drug regimen including clarithromycin and rifabutin was started. Gamma interferon has been helpful in addition to antimycobacterial treatment for one patient.

Conclusion

Clinicians should be aware that M. genavense could be the etiologic agent of sub-acute pneumonia mimicking tuberculosis in patients with cellular immunodeficiency status.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mortellaro A, Robinson L, Ricciardi-Castagnoli P: Spotlight on Mycobacteria and dendritic cells: will novel targets to fight tuberculosis emerge?. EMBO Mol Med. 2009, 1 (1): 19-29. 10.1002/emmm.200900008.CrossRefPubMedPubMedCentral Mortellaro A, Robinson L, Ricciardi-Castagnoli P: Spotlight on Mycobacteria and dendritic cells: will novel targets to fight tuberculosis emerge?. EMBO Mol Med. 2009, 1 (1): 19-29. 10.1002/emmm.200900008.CrossRefPubMedPubMedCentral
2.
go back to reference Glassroth J: Pulmonary disease due to nontuberculous mycobacteria. Chest. 2008, 133 (1): 243-251. 10.1378/chest.07-0358.CrossRefPubMed Glassroth J: Pulmonary disease due to nontuberculous mycobacteria. Chest. 2008, 133 (1): 243-251. 10.1378/chest.07-0358.CrossRefPubMed
3.
go back to reference Hillebrand-Haverkort ME, Kolk AH, Kox LF, Ten Velden JJ, Ten Veen JH: Generalized mycobacterium genavense infection in HIV-infected patients: detection of the mycobacterium in hospital tap water. Scand J Infect Dis. 1999, 31 (1): 63-68. 10.1080/00365549950161907.CrossRefPubMed Hillebrand-Haverkort ME, Kolk AH, Kox LF, Ten Velden JJ, Ten Veen JH: Generalized mycobacterium genavense infection in HIV-infected patients: detection of the mycobacterium in hospital tap water. Scand J Infect Dis. 1999, 31 (1): 63-68. 10.1080/00365549950161907.CrossRefPubMed
4.
go back to reference Manarolla G, Liandris E, Pisoni G, Sassera D, Grilli G, Gallazzi D, Sironi G, Moroni P, Piccinini R, Rampin T: Avian mycobacteriosis in companion birds: 20-year survey. Vet Microbiol. 2009, 133 (4): 323-327. 10.1016/j.vetmic.2008.07.017.CrossRefPubMed Manarolla G, Liandris E, Pisoni G, Sassera D, Grilli G, Gallazzi D, Sironi G, Moroni P, Piccinini R, Rampin T: Avian mycobacteriosis in companion birds: 20-year survey. Vet Microbiol. 2009, 133 (4): 323-327. 10.1016/j.vetmic.2008.07.017.CrossRefPubMed
5.
go back to reference Bessesen MT, Shlay J, Stone-Venohr B, Cohn DL, Reves RR: Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy. AIDS. 1993, 7 (10): 1357-1361. 10.1097/00002030-199310000-00009.CrossRefPubMed Bessesen MT, Shlay J, Stone-Venohr B, Cohn DL, Reves RR: Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy. AIDS. 1993, 7 (10): 1357-1361. 10.1097/00002030-199310000-00009.CrossRefPubMed
6.
go back to reference Lu KJ, Grigg A, Leslie D, Finlay M, Sasadeusz J: Mycobacterium genavense duodenitis following allogeneic peripheral blood stem cell transplantation. Transpl Infect Dis. 2009, 11 (6): 534-536. 10.1111/j.1399-3062.2009.00431.x.CrossRefPubMed Lu KJ, Grigg A, Leslie D, Finlay M, Sasadeusz J: Mycobacterium genavense duodenitis following allogeneic peripheral blood stem cell transplantation. Transpl Infect Dis. 2009, 11 (6): 534-536. 10.1111/j.1399-3062.2009.00431.x.CrossRefPubMed
7.
go back to reference Bogdan C, Kern P, Richter E, Tannapfel A, Rusch-Gerdes S, Kirchner T, Solbach W: Systemic infection with Mycobacterium genavense following immunosuppressive therapy in a patient who was seronegative for human immunodeficiency virus. Clin Infect Dis. 1997, 24 (6): 1245-1247. 10.1086/513634.CrossRefPubMed Bogdan C, Kern P, Richter E, Tannapfel A, Rusch-Gerdes S, Kirchner T, Solbach W: Systemic infection with Mycobacterium genavense following immunosuppressive therapy in a patient who was seronegative for human immunodeficiency virus. Clin Infect Dis. 1997, 24 (6): 1245-1247. 10.1086/513634.CrossRefPubMed
8.
go back to reference Charles P, Lortholary O, Dechartres A, Doustar F, Viard J-P, Lecuit M, Gutierrez MC, Group TFMgS: Mycobacterium genavense Infections: a retrospective Multicenter Study between 1996 and 2007 in France. Medicine. 2011, 90 (4): 223-30. 10.1097/MD.0b013e318225ab89.CrossRefPubMed Charles P, Lortholary O, Dechartres A, Doustar F, Viard J-P, Lecuit M, Gutierrez MC, Group TFMgS: Mycobacterium genavense Infections: a retrospective Multicenter Study between 1996 and 2007 in France. Medicine. 2011, 90 (4): 223-30. 10.1097/MD.0b013e318225ab89.CrossRefPubMed
9.
go back to reference Tortoli E, Brunello F, Cagni AE, Colombrita D, Dionisio D, Grisendi L, Manfrin V, Moroni M, Passerini Tosi C, Pinsi G, et al: Mycobacterium genavense in AIDS patients, report of 24 cases in Italy and review of the literature. Eur J Epidemiol. 1998, 14 (3): 219-224. 10.1023/A:1007401305708.CrossRefPubMed Tortoli E, Brunello F, Cagni AE, Colombrita D, Dionisio D, Grisendi L, Manfrin V, Moroni M, Passerini Tosi C, Pinsi G, et al: Mycobacterium genavense in AIDS patients, report of 24 cases in Italy and review of the literature. Eur J Epidemiol. 1998, 14 (3): 219-224. 10.1023/A:1007401305708.CrossRefPubMed
10.
go back to reference Nurmohamed S, Weenink A, Moeniralam H, Visser C, Bemelman F: Hyperammonemia in generalized Mycobacterium genavense infection after renal transplantation. Am J Transplant. 2007, 7 (3): 722-723. 10.1111/j.1600-6143.2006.01680.x.CrossRefPubMed Nurmohamed S, Weenink A, Moeniralam H, Visser C, Bemelman F: Hyperammonemia in generalized Mycobacterium genavense infection after renal transplantation. Am J Transplant. 2007, 7 (3): 722-723. 10.1111/j.1600-6143.2006.01680.x.CrossRefPubMed
11.
go back to reference de Lastours V, Guillemain R, Mainardi JL, Aubert A, Chevalier P, Lefort A, Podglajen I: Early diagnosis of disseminated Mycobacterium genavense infection. Emerg Infect Dis. 2008, 14 (2): 346-347. 10.3201/eid1402.070901.CrossRefPubMedPubMedCentral de Lastours V, Guillemain R, Mainardi JL, Aubert A, Chevalier P, Lefort A, Podglajen I: Early diagnosis of disseminated Mycobacterium genavense infection. Emerg Infect Dis. 2008, 14 (2): 346-347. 10.3201/eid1402.070901.CrossRefPubMedPubMedCentral
12.
go back to reference Pechere M, Opravil M, Wald A, Chave JP, Bessesen M, Sievers A, Hein R, von Overbeck J, Clark RA, Tortoli E, et al: Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study. Arch Intern Med. 1995, 155 (4): 400-404. 10.1001/archinte.155.4.400.CrossRefPubMed Pechere M, Opravil M, Wald A, Chave JP, Bessesen M, Sievers A, Hein R, von Overbeck J, Clark RA, Tortoli E, et al: Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study. Arch Intern Med. 1995, 155 (4): 400-404. 10.1001/archinte.155.4.400.CrossRefPubMed
13.
go back to reference Thomsen VO, Dragsted UB, Bauer J, Fuursted K, Lundgren J: Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists. J Clin Microbiol. 1999, 37 (12): 3901-3905.PubMedPubMedCentral Thomsen VO, Dragsted UB, Bauer J, Fuursted K, Lundgren J: Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists. J Clin Microbiol. 1999, 37 (12): 3901-3905.PubMedPubMedCentral
14.
go back to reference Dumonceau JM, Van Gossum A, Adler M, Van Vooren JP, Fonteyne PA, De Beenhouwer H, Portaels F: Detection of fastidious mycobacteria in human intestines by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis. 1997, 16 (5): 358-363. 10.1007/BF01726363.CrossRefPubMed Dumonceau JM, Van Gossum A, Adler M, Van Vooren JP, Fonteyne PA, De Beenhouwer H, Portaels F: Detection of fastidious mycobacteria in human intestines by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis. 1997, 16 (5): 358-363. 10.1007/BF01726363.CrossRefPubMed
15.
go back to reference Delpire P, Farber CM, Portaels F, Struelens M, Clevenbergh P, Dargent JL, Delpace J, Mehdi A, Van Vooren JP: Splenectomy in a patients with AIDS, generalized Mycobacterium genavense infection and severe pancytopenia. Tuber Lung Dis. 1996, 77 (6): 569-570. 10.1016/S0962-8479(96)90059-3.CrossRefPubMed Delpire P, Farber CM, Portaels F, Struelens M, Clevenbergh P, Dargent JL, Delpace J, Mehdi A, Van Vooren JP: Splenectomy in a patients with AIDS, generalized Mycobacterium genavense infection and severe pancytopenia. Tuber Lung Dis. 1996, 77 (6): 569-570. 10.1016/S0962-8479(96)90059-3.CrossRefPubMed
16.
go back to reference Krebs T, Zimmerli S, Bodmer T, Lammle B: Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukaemia. J Intern Med. 2000, 248 (4): 343-348. 10.1046/j.1365-2796.2000.00730.x.CrossRefPubMed Krebs T, Zimmerli S, Bodmer T, Lammle B: Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukaemia. J Intern Med. 2000, 248 (4): 343-348. 10.1046/j.1365-2796.2000.00730.x.CrossRefPubMed
17.
go back to reference Leautez S, Boutoille D, Bemer-Melchior P, Ponge T, Raffi F: Localized Mycobacterium genavense soft tissue infection in an immunodeficient HIV-negative patient. Eur J Clin Microbiol Infect Dis. 2000, 19 (1): 51-52. 10.1007/s100960050010.CrossRefPubMed Leautez S, Boutoille D, Bemer-Melchior P, Ponge T, Raffi F: Localized Mycobacterium genavense soft tissue infection in an immunodeficient HIV-negative patient. Eur J Clin Microbiol Infect Dis. 2000, 19 (1): 51-52. 10.1007/s100960050010.CrossRefPubMed
18.
go back to reference Trueba F, Fabre M, Saint-Blancard P: Rapid identification of Mycobacterium genavense with a new commercially available molecular test, INNO-LiPA MYCOBACTERIA v2. J Clin Microbiol. 2004, 42 (9): 4403-4404. 10.1128/JCM.42.9.4403-4404.2004.CrossRefPubMedPubMedCentral Trueba F, Fabre M, Saint-Blancard P: Rapid identification of Mycobacterium genavense with a new commercially available molecular test, INNO-LiPA MYCOBACTERIA v2. J Clin Microbiol. 2004, 42 (9): 4403-4404. 10.1128/JCM.42.9.4403-4404.2004.CrossRefPubMedPubMedCentral
19.
go back to reference Ninet B, Rutschmann O, Burkhardt K, Metral C, Borisch B, Hirschel B: Detection of mycobacterial nucleic acids by polymerase chain reaction in fixed tissue specimens of patients with human immunodeficiency virus infection. Swiss HIV Cohort Study. Diagn Mol Pathol. 1999, 8 (3): 145-151. 10.1097/00019606-199909000-00007.CrossRefPubMed Ninet B, Rutschmann O, Burkhardt K, Metral C, Borisch B, Hirschel B: Detection of mycobacterial nucleic acids by polymerase chain reaction in fixed tissue specimens of patients with human immunodeficiency virus infection. Swiss HIV Cohort Study. Diagn Mol Pathol. 1999, 8 (3): 145-151. 10.1097/00019606-199909000-00007.CrossRefPubMed
20.
go back to reference Chevrier D, Oprisan G, Maresca A, Matsiota-Bernard P, Guesdon JL: Isolation of a specific DNA fragment and development of a PCR-based method for the detection of Mycobacterium genavense. FEMS Immunol Med Microbiol. 1999, 23 (3): 243-252. 10.1111/j.1574-695X.1999.tb01245.x.CrossRefPubMed Chevrier D, Oprisan G, Maresca A, Matsiota-Bernard P, Guesdon JL: Isolation of a specific DNA fragment and development of a PCR-based method for the detection of Mycobacterium genavense. FEMS Immunol Med Microbiol. 1999, 23 (3): 243-252. 10.1111/j.1574-695X.1999.tb01245.x.CrossRefPubMed
21.
go back to reference Albrecht H, Rusch-Gerdes S, Stellbrink HJ, Greten H, Jackle S: Disseminated Mycobacterium genavense infection as a cause of pseudo-Whipple's disease and sclerosing cholangitis. Clin Infect Dis. 1997, 25 (3): 742-743. 10.1086/516941.CrossRefPubMed Albrecht H, Rusch-Gerdes S, Stellbrink HJ, Greten H, Jackle S: Disseminated Mycobacterium genavense infection as a cause of pseudo-Whipple's disease and sclerosing cholangitis. Clin Infect Dis. 1997, 25 (3): 742-743. 10.1086/516941.CrossRefPubMed
22.
go back to reference Casanova JL, Abel L: Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002, 20: 581-620. 10.1146/annurev.immunol.20.081501.125851.CrossRefPubMed Casanova JL, Abel L: Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002, 20: 581-620. 10.1146/annurev.immunol.20.081501.125851.CrossRefPubMed
23.
go back to reference Matsiota-Bernard P, Vilde F, Nauciel C: Mycobacterium genavense infection in normal and immunodeficient mice. Microbes Infect. 2000, 2 (6): 575-580. 10.1016/S1286-4579(00)00369-5.CrossRefPubMed Matsiota-Bernard P, Vilde F, Nauciel C: Mycobacterium genavense infection in normal and immunodeficient mice. Microbes Infect. 2000, 2 (6): 575-580. 10.1016/S1286-4579(00)00369-5.CrossRefPubMed
24.
go back to reference Catherinot E, Lanternier F, Bougnoux ME, Lecuit M, Couderc LJ, Lortholary O: Pneumocystis jirovecii Pneumonia. Infect Dis Clin North Am. 24 (1): 107-138. Catherinot E, Lanternier F, Bougnoux ME, Lecuit M, Couderc LJ, Lortholary O: Pneumocystis jirovecii Pneumonia. Infect Dis Clin North Am. 24 (1): 107-138.
25.
go back to reference Vrioni G, Nauciel C, Kerharo G, Matsiota-Bernard P: Treatment of disseminated Mycobacterium genavense infection in a murine model with ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin. J Antimicrob Chemother. 1998, 42 (4): 483-487. 10.1093/jac/42.4.483.CrossRefPubMed Vrioni G, Nauciel C, Kerharo G, Matsiota-Bernard P: Treatment of disseminated Mycobacterium genavense infection in a murine model with ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin. J Antimicrob Chemother. 1998, 42 (4): 483-487. 10.1093/jac/42.4.483.CrossRefPubMed
26.
go back to reference Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al: An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007, 175 (4): 367-416. 10.1164/rccm.200604-571ST.CrossRefPubMed Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al: An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007, 175 (4): 367-416. 10.1164/rccm.200604-571ST.CrossRefPubMed
27.
go back to reference Ehlers S, Richter E: Gamma interferon is essential for clearing Mycobacterium genavense infection. Infect Immun. 2000, 68 (6): 3720-3723. 10.1128/IAI.68.6.3720-3723.2000.CrossRefPubMedPubMedCentral Ehlers S, Richter E: Gamma interferon is essential for clearing Mycobacterium genavense infection. Infect Immun. 2000, 68 (6): 3720-3723. 10.1128/IAI.68.6.3720-3723.2000.CrossRefPubMedPubMedCentral
28.
go back to reference Kedzierska K, Azzam R, Ellery P, Mak J, Jaworowski A, Crowe SM: Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. J Clin Virol. 2003, 26 (2): 247-263. 10.1016/S1386-6532(02)00123-3.CrossRefPubMed Kedzierska K, Azzam R, Ellery P, Mak J, Jaworowski A, Crowe SM: Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. J Clin Virol. 2003, 26 (2): 247-263. 10.1016/S1386-6532(02)00123-3.CrossRefPubMed
Metadata
Title
Mycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiency
Authors
Blandine Rammaert
Louis-Jean Couderc
Elisabeth Rivaud
Patrick Honderlick
David Zucman
Marie-France Mamzer
Pierre Cahen
Emmanuel Bille
Marc Lecuit
Olivier Lortholary
Emilie Catherinot
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-311

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.